Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients.

Margot A CousinEric T MateyPatrick R Blackburn Nicole J BoczekTammy M McAllisterTeresa M KruisselbrinkDusica Babovic-VuksanovicKonstantinos N LazaridisEric W Klee

Published in: Molecular genetics & genomic medicine (2017)

Due to the disease complexity and medication needs of diagnostic odyssey patients, there may be immediate benefit obtained from early life PGx testing for many and most will likely find benefit in the future. These results require conscientious interpretation and management to be actionable for all prescribing physicians throughout the lifetime of the patient.

Keyphrases

end stage renal disease
primary care
newly diagnosed
ejection fraction
chronic kidney disease
early life
emergency department
patient reported outcomes
case report